Amneal Pharmaceuticals, Inc. Income Statement
AMRX / Health Care|10 years of annual SEC 10-K data (FY2016-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 10 fiscal years. All figures from audited SEC 10-K filings.
Amneal Pharmaceuticals, Inc. reported $3.0B in revenue and $72M in net income for FY2025. Revenue has grown at a 12.8% compound annual rate over the past 9 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0B | $2.8B | $2.1B | $2.2B | $1.6B | $1.7B | $1.0B | $1.0B | $1.0B | $1.0B |
| Cost of Revenue | $1.9B | $1.8B | $1.3B | $1.4B | $1.1B | $938.8M | $507.5M | $420.8M | $507.5M | $420.8M |
| Gross Profit | $1.1B | $1.0B | $769.0M | $784.7M | $353.0M | $716.4M | $526.2M | $597.5M | $526.2M | $597.5M |
| SG&A Expense | $526.8M | $476.4M | $365.5M | $399.7M | $289.6M | $227.8M | $109.0M | $118.8M | $109.0M | $118.8M |
| R&D Expense | $186.2M | $190.7M | $201.8M | $195.7M | $188.0M | $194.2M | $171.4M | $179.0M | $171.4M | $179.0M |
| Operating Income | $394.1M | $249.3M | $152.7M | -$94.9M | -$248.7M | -$19.7M | $245.1M | $284.9M | $245.1M | $284.9M |
| Income Tax | $11.3M | $18.9M | $11.2M | $6.7M | $383.3M | -$1.4M | $2.0M | $5.4M | $2.0M | $5.4M |
| Net Income | $72.1M | -$116.9M | $13.2M | -$270.6M | -$603.6M | -$19.7M | $0 | $0 | $0 | $0 |
| EPS (Basic) | $0.23 | -$0.86 | $0.07 | $0.62 | -$2.74 | -$0.16 | -$0.37 | $0.00 | - | - |
| EPS (Diluted) | $0.22 | -$0.86 | $0.07 | $0.61 | -$2.74 | -$0.16 | -$0.37 | $0.00 | - | - |
| Shares Outstanding | 324.8M | 150.9M | 151.8M | 148.9M | 132.1M | 127.3M | 127.3M | 127.3M | 1.0K | - |
| Gross Margin | 36.9% | 36.5% | 36.7% | 35.5% | 21.7% | 43.1% | 50.9% | 58.7% | 50.9% | 58.7% |
| Operating Margin | 13.1% | 8.9% | 7.3% | -4.3% | -15.3% | -1.2% | 23.7% | 28.0% | 23.7% | 28.0% |
| Profit Margin | 2.4% | -4.2% | 0.6% | -12.2% | -37.1% | -1.2% | 0.0% | 0.0% | 0.0% | 0.0% |